Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Gross Profit: 2011-2025

Historic Gross Profit for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $65.3 million.

  • Enanta Pharmaceuticals' Gross Profit rose 3.55% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.3 million, marking a year-over-year decrease of 3.42%. This contributed to the annual value of $65.3 million for FY2025, which is 3.42% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Gross Profit of $65.3 million as of FY2025, which was down 3.42% from $67.6 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Gross Profit registered a high of $97.1 million during FY2021, and its lowest value of $65.3 million during FY2025.
  • For the 3-year period, Enanta Pharmaceuticals' Gross Profit averaged around $70.7 million, with its median value being $67.6 million (2024).
  • Data for Enanta Pharmaceuticals' Gross Profit shows a maximum YoY declined of 20.74% (in 2021) over the last 5 years.
  • Enanta Pharmaceuticals' Gross Profit (Yearly) stood at $97.1 million in 2021, then declined by 11.24% to $86.2 million in 2022, then decreased by 8.07% to $79.2 million in 2023, then decreased by 14.61% to $67.6 million in 2024, then dropped by 3.42% to $65.3 million in 2025.